Results 1 to 10 of about 515 (119)
Left Atrial Appendage Occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021 The majority of embolic strokes in patients with nonvalvular atrial fibrillation are caused by thrombi in the left atrial appendage. It is projected that strokes related to atrial fibrillation will markedly increase in the future unless effective ...
Fareed Moses S. Collado +7 more
doaj +3 more sources
Left atrial appendage occlusion
International Journal of Preventive Medicine, 2013 Left atrial appendage (LAA) occlusion is a treatment strategy to prevent blood clot formation in atrial appendage. Although, LAA occlusion usually was done by catheter-based techniques, especially percutaneous trans-luminal mitral commissurotomy (PTMC ...
Ahmad Mirdamadi +3 more
doaj +4 more sources
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023 Background The LAAOS III (Left Atrial Appendage Occlusion Study) clinical trial demonstrated that concomitant left atrial appendage (LAA) occlusion leads to a lower risk of ischemic stroke or systemic embolism compared with no occlusion in participants ...
Adam Eqbal +12 more
doaj +3 more sources
The NCDR Left Atrial Appendage Occlusion Registry
Journal of the American College of Cardiology, 2020 Left atrial appendage occlusion (LAAO) to prevent stroke in patients with atrial fibrillation has been evaluated in 2 randomized trials; post-approval clinical data are limited.The purpose of this study was to describe the National Cardiovascular Data Registry (NCDR) LAAO Registry and present patient, hospital, and physician characteristics and in ...
Frederick A Masoudi
exaly +3 more sources
Left atrial appendage occlusion [PDF]
Nature Reviews Cardiology, 2023 Prevention of stroke represents a goal of primary importance in health systems due to its associated morbidity and mortality. As several patient groups with increased stroke rates have been identified, multiple approaches have been developed and implemented: oral anticoagulation (OAC) for patients with atrial fibrillation, surgical and percutaneous ...
David R, Holmes +5 more
+7 more sources
JACC: Case Reports, 2020 A patient with a left atrial appendage occlusion device underwent mitral valve replacement. Later, the patient developed a left atrial thrombosis with thromboembolic myocardial infarction caused by a dislocation of the occlusion device.
Moritz B. Immohr, MD +3 more
doaj +1 more source
Left Atrial Appendage Occlusion
JACC: Advances, 2022 The field of left atrial appendage occlusion is rapidly evolving. However, several issues remain including the limited randomized efficacy data, peri-device leak, device-related thrombus, and the ongoing refinement of procedural techniques. In this article, we provide a contemporary overview of left atrial appendage occlusion focusing on 4 key ...
Mohamad Alkhouli +5 more
+6 more sources
Diseases, 2023 Left atrial appendage occlusion affects systemic coagulation parameters, leading to additional patient-related benefits. The aim of this study was to investigate the differences in coagulation factor changes 6 months after epicardial left atrial ...
Jakub Batko +11 more
doaj +1 more source
Percutaneous Left Atrial Appendage Occlusion [PDF]
Cardiology, 2020 n ...
Sambola, Antonia +2 more
openaire +3 more sources
1% Aspiration, 99% Perspiration
JACC: Case Reports, 2020 A 71-year-old man with chronic atrial fibrillation underwent insertion of a left atrial appendage occlusion device. Before release, a large thrombus was noted within the left atrium, attached to the left atrial appendage occluder delivery system.
Pankaj Jain, MBBS +3 more
doaj +1 more source